These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8112846)

  • 41. Inefficient binding of IgM immune complexes to erythrocyte C3b-C4b receptors (CR1) and weak incorporation of C3b-iC3b into the complexes.
    Kávai M; Rasmussen JM; Baatrup G; Zsindely A; Svehag SE
    Scand J Immunol; 1988 Jul; 28(1):123-8. PubMed ID: 2969612
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products.
    Farries TC; Lachmann PJ; Harrison RA
    Biochem J; 1988 May; 252(1):47-54. PubMed ID: 3421908
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endogenous interleukin (IL)-1 alpha and IL-1 beta are crucial for host defense against disseminated candidiasis.
    Vonk AG; Netea MG; van Krieken JH; Iwakura Y; van der Meer JW; Kullberg BJ
    J Infect Dis; 2006 May; 193(10):1419-26. PubMed ID: 16619190
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of ethylenediaminetetraacetate and metal ions in intestinal absorption of vitamin B 12 in man and rats.
    Okuda K; Sasayama K
    Proc Soc Exp Biol Med; 1965 Oct; 120(1):17-20. PubMed ID: 4954990
    [No Abstract]   [Full Text] [Related]  

  • 45. Suboptimal C3b/C3bi deposition and defective yeast opsonization. I. Evidence for the absence of essential co-factor activity.
    Turner MW; Seymour ND; Kazatchkine MD; Mowbray JF
    Clin Exp Immunol; 1985 Nov; 62(2):427-34. PubMed ID: 2935338
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characteristics of iC3b binding to human polymorphonuclear leucocytes.
    Gordon DL; Johnson GM; Hostetter MK
    Immunology; 1987 Apr; 60(4):553-8. PubMed ID: 2953669
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of Mg(2+), Ca(2+), Sr(2+) and Ba(2+) metal ions on the antifungal activity of ZnO nanoparticles tested against Candida albicans.
    Haja Hameed AS; Karthikeyan C; Senthil Kumar V; Kumaresan S; Sasikumar S
    Mater Sci Eng C Mater Biol Appl; 2015; 52():171-7. PubMed ID: 25953555
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The TEA/ATTS transcription factor CaTec1p regulates hyphal development and virulence in Candida albicans.
    Schweizer A; Rupp S; Taylor BN; Röllinghoff M; Schröppel K
    Mol Microbiol; 2000 Nov; 38(3):435-45. PubMed ID: 11069668
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The hyphal and yeast forms of Candida albicans bind the complement regulator C4b-binding protein.
    Meri T; Blom AM; Hartmann A; Lenk D; Meri S; Zipfel PF
    Infect Immun; 2004 Nov; 72(11):6633-41. PubMed ID: 15501796
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Different immunofluorescent titres of Candida albicans blastospores and pseudohyphae.
    Haneke E
    Mycopathol Mycol Appl; 1974 Apr; 52(3):269-71. PubMed ID: 4210119
    [No Abstract]   [Full Text] [Related]  

  • 51. Secreted pH-regulated antigen 1 of Candida albicans blocks activation and conversion of complement C3.
    Luo S; Hartmann A; Dahse HM; Skerka C; Zipfel PF
    J Immunol; 2010 Aug; 185(4):2164-73. PubMed ID: 20644161
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The attachment of serum- and plasma-derived C3 to solid-phase immune aggregates and its relation to complement-mediated solubilization of immune complexes.
    Baatrup G; Svehag SE; Jensenius JC
    Scand J Immunol; 1986 Apr; 23(4):397-406. PubMed ID: 3486458
    [TBL] [Abstract][Full Text] [Related]  

  • 53. C3b binding, but not its breakdown, is affected by the structure of the O-antigen polysaccharide in lipopolysaccharide from Salmonellae.
    Grossman N; Joiner KA; Frank MM; Leive L
    J Immunol; 1986 Mar; 136(6):2208-15. PubMed ID: 3950413
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bovine conglutinin binds to an oligosaccharide determinant presented by iC3b, but not by C3, C3b or C3c.
    Laursen SB; Thiel S; Teisner B; Holmskov U; Wang Y; Sim RB; Jensenius JC
    Immunology; 1994 Apr; 81(4):648-54. PubMed ID: 7518801
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The leukocyte integrin p150,95 (CD11c/CD18) as a receptor for iC3b. Activation by a heterologous beta subunit and localization of a ligand recognition site to the I domain.
    Bilsland CA; Diamond MS; Springer TA
    J Immunol; 1994 May; 152(9):4582-9. PubMed ID: 7512600
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interaction of iC3b with recombinant isotypic and chimeric forms of CR2.
    Kalli KR; Ahearn JM; Fearon DT
    J Immunol; 1991 Jul; 147(2):590-4. PubMed ID: 1830068
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adherence of Candida species to human epidermal corneocytes and buccal mucosal cells: correlation with cutaneous pathogenicity.
    Ray TL; Digre KB; Payne CD
    J Invest Dermatol; 1984 Jul; 83(1):37-41. PubMed ID: 6429252
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Distribution of activated complement, C3b, and its degraded fragments, iC3b/C3dg, in the colonic mucosa of ulcerative colitis (UC).
    Ueki T; Mizuno M; Uesu T; Kiso T; Nasu J; Inaba T; Kihara Y; Matsuoka Y; Okada H; Fujita T; Tsuji T
    Clin Exp Immunol; 1996 May; 104(2):286-92. PubMed ID: 8625522
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potentiation of NK cytotoxicity by antibody-C3b/iC3b heteroconjugates.
    Yefenof E; Benizri R; Reiter Y; Klein E; Fishelson Z
    J Immunol; 1990 Feb; 144(4):1538-43. PubMed ID: 2303717
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of the differentiation of Candida albicans by the chelator 1,10-phenanthroline.
    Bedell GW; Anderson RV
    Mycopathologia; 1985 Dec; 92(3):161-7. PubMed ID: 3937057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.